Qiagen N.V.

NYSE:QGEN

Medical - Diagnostics & Research

Healthcare
$49.56 -0.96%

-$0.35 today

Market cap
$10.23B
Beta
0.66
P/E (TTM)
18.6
EPS (TTM)
$1.94
Dividend yield
0.69%
52W Low $32.53High $57.82

Volume 4.26M

Average 2.07M

QGEN Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Qiagen N.V.NYSE: QGEN

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin widens to 19.3%

Net margin was 19.3% in Q2 FY2026, up 1.3 pp from a year earlier. On a trailing-twelve-month basis it was 19.5%, up 1.2 pp year over year. Over 3 fiscal years it widened by 0.6 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 11 analysts of 23.9% for the fiscal year ending Dec 2026, up from 20.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
19.3%+5.5 pp QoQ
Last fiscal yearDec 2025
20.3%+16.1 pp YoY
LTMJun 2026
19.5%+1.2 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.3 pp-0.2 pp-1.5 pp
1 year+16.1 pp+3.5 pp-12.6 pp
3 years+0.6 pp+5.5 pp+4.9 pp
5 years+6.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
20.3%
Year-over-year change
+16.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How QGEN compares with its peers on the latest reported figures

  • QGEN's LTM Jun 2026 net margin of 19.5% is the 2nd highest of the 11 companies compared; the peer median is 8.4%.
  • Its year-over-year change of +1.2 pp is the 6th highest of 11, against a peer median of +1.3 pp.
  • Over three fiscal years its change of +0.6 pp compares with a peer median of -9.4 pp.
QGEN Competitors Peer median
Net Margin for QGEN and competitors
Company Period LTM level YoY 3-year change
AAgilent Technologies, Inc.LTM Jul 202619.5% +1.6 pp+0.4 pp
QGENQiagen N.V.LTM Jun 202619.5% +1.2 pp+0.6 pp
DHRDanaher CorporationLTM Sep 202616.9% +2.5 pp-12.3 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202615.0% -0.1 pp-0.4 pp
TECHBio-Techne CorporationLTM Sep 202614.0% +7.6 pp-10.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 20268.6% -3.9 pp+158.9 pp
RVTYRevvity, Inc.LTM Jul 20268.2% -2.1 pp-8.7 pp
RGENRepligen CorporationLTM Jun 20265.3% +7.3 pp-16.6 pp
BRKRBruker CorporationLTM Jun 2026-2.0% -4.3 pp-12.0 pp
TXG10x Genomics, Inc.LTM Sep 2026-10.8% +1.0 pp+25.4 pp
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026-37.1% +53.1 pp-95.3 pp
Peer median (excluding QGEN) 8.4%+1.3 pp-9.4 pp

Competitors are the stored peer set for QGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.25B2.14B1.97B1.98B2.09B
Cost of Revenue800.84M756.96M731.62M1.01B798.5M
Gross Profit1.45B1.38B1.23B967.35M1.29B
Gross Margin64.4%64.7%62.8%48.9%61.8%
Research & Development189.96M189.86M198.51M193.49M187.52M
Selling, General & Admin584.47M603.95M579.17M564.36M583.67M
Operating Expenses820.74M853.1M823.75M869.64M771.19M
Depreciation & Amortization214.93M208.4M205.34M203.27M193.75M
EBITDA895.24M779.36M688.56M368.26M717.27M
EBITDA Margin39.8%36.4%35.0%18.6%34.3%
Operating Income630.08M531.46M409.94M97.71M520.31M
Operating Margin28.0%24.8%20.9%4.9%24.9%
Interest Income9.56M32.76M78.99M68.02M64.32M
Interest Expense54.48M58.36M53.41M43.84M33.26M
Other Income / Expenses(4.25M)(18.86M)19.87M23.44M(30.04M)
Income Before Tax625.83M512.6M429.81M121.15M490.27M
Pre-Tax Margin27.8%23.9%21.9%6.1%23.5%
Income Tax Expense113.23M89.39M88.51M37.56M65.39M
Net Income512.6M423.21M341.3M83.59M424.88M
Net Margin22.8%19.8%17.4%4.2%20.3%
EPS (Basic)2.522.081.670.392.04
EPS (Diluted)2.472.051.650.382.04
Weighted Avg Shares221.14M220.75M217.49M216.44M207.94M
Weighted Avg Shares (Diluted)225.07M223.23M217.49M218.48M207.94M

Qiagen N.V.

NYSE:QGEN

Intrinsic Alpha fair value

Locked

Current Price

$49.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.